Research News and Research

RSS

Microbiologist receives contract from U.S. DOD to develop vaccine against tularemia

Microbiologist Karl Klose, a professor in the UTSA College of Sciences' Department of Biology and a member of the South Texas Center for Emerging Infectious Diseases, has received a contract from the U.S. Department of Defense (DOD) to conduct research that would bring scholars one step closer to developing a vaccine against tularemia.

14 Aug 2014

Research and planning to meet health needs of people living with HIV

As effective treatments for HIV become more widely available in low- and middle-income countries, there's an urgent need to assess and manage health risks in the growing number of people living with HIV.

14 Aug 2014

Health institutions tackle high rate of preterm birth

An estimated 15 million babies are born preterm every year and more than one million die within the first 30 days after birth.

14 Aug 2014

Researchers examine advantages of being married to physician

Physicians tend to marry later and their marriages last longer even as they face the challenges, like others with demanding professions, of giving time and attention to their partners and families.

14 Aug 2014

World Health Organization approves use of experimental Ebola treatment

The drugs have not yet been through FDA testing, but WHO says they can be used for "compassionate use" to help in the African outbreak. However, manufacturers may not have many supplies available.

14 Aug 2014

New program creates gap between cutting-edge academic research and market uptake

Four University of California, Davis, researchers have been given $50,000 each in the inaugural year of a competitive grant program aimed at facilitating the conversion of technology generated from university research into commercial applications.

14 Aug 2014

Reducing brain levels of tau protein effectively blocks development of childhood epilepsy

Researchers at the Gladstone Institutes have shown that reducing brain levels of the protein tau effectively blocks the development of disease in a mouse model of Dravet syndrome, a severe intractable form of childhood epilepsy.

14 Aug 2014

Researchers discover new clue to understanding how TB medication attacks dormant TB bacteria

Researchers at the Johns Hopkins Bloomberg School of Public Health say they have discovered a new clue to understanding how the most important medication for tuberculosis (TB) works to attack dormant TB bacteria in order to shorten treatment.

13 Aug 2014

MicroVAX begins phase I clinical trial for proprietary cancer vaccine platform

MicroVAX, LLC, a biotech company located in Manassas, Virginia announced today the commencement of a phase I clinical trial for its unique and proprietary vaccine platform that allows under the provisions of an FDA IND entry of patients with cancers of the, breast, prostate, colon, ovary and lung, that have relapsed after initial salvage therapy.

13 Aug 2014

Researchers make significant step forward in understanding mechanisms that cause leukaemia

Scientists from Queen Mary University of London have discovered mutations in genes that lead to childhood leukaemia of the acute lymphoblastic type - the most common childhood cancer in the world.

13 Aug 2014

iTAKL study receives $3.8 million NIH grant to examine effects of head impacts in youth league football

Wake Forest Baptist Medical Center has received a $3.8 million, five-year grant from the National Institute for Neurological Disorders and Stroke, part of the National Institutes of Health, to continue studying the effects of head impacts in youth league football.

13 Aug 2014

High-dose influenza vaccine 24% more effective in older adults

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications, according to a Vanderbilt-led study published today in the New England Journal of Medicine.

13 Aug 2014